SCHEMBL24166399

SCHEMBL24166399

c1ccc(C2(c3cccc(Nc4ccc5ccccc5c4)c3)c3ccccc3-c3ccccc32)cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.56
CYP3A4 P08684 2/20 0.56
HSD17B10 Q99714 2/20 0.56
HPGD P15428 1/20 0.56
PDK2 Q15119 1/20 0.42
MEN1 O00255 4/20 0.40
KMT2A Q03164 4/20 0.40
POLB P06746 1/20 0.40
SNCA P37840 1/20 0.39
MAPT P10636 7/20 0.39
LMNA P02545 3/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KDM4E B2RXH2 1/20 0.39
OPRK1 P41145 1/20 0.39
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
AR P10275 1/20 0.38
ESR1 P03372 1/20 0.37
ESR2 Q92731 1/20 0.37
MAPK1 P28482 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23697089 0.91 ALDH1A1 (0.51) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL30455829 0.90 ALDH1A1 (0.53) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL15677716 0.90 ALDH1A1 (0.53) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL23697143 0.88 ALDH1A1 (0.49) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL23658608 0.88 PDK2 (0.49) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL15222375 0.88 ALDH1A1 (0.58) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL1645319 0.88 MEN1 (0.50) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL24166592 0.87 ALDH1A1 (0.44) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL20871538 0.87 MAPT (0.46) ALDH1A1CYP3A4HSD17B10HPGDPDK2
SCHEMBL20871518 0.87 PDK2 (0.51) ALDH1A1CYP3A4HSD17B10HPGDPDK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME DUK SAN NEOLUX CO., LTD. (KR) 2023-06-15 US disclosed
WO-2022004994-A1 COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME 덕산네오룩스 주식회사 2022-01-06 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230183201-A1 COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE HAVING SAME ORAI2, OR10J3, OR51E2 ALDH1A1 2208/4885CYP3A4 2826/4885HSD17B10 3658/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.